Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN NATCO PHARMA LUPIN/
NATCO PHARMA
 
P/E (TTM) x 40.7 13.3 305.4% View Chart
P/BV x 6.0 3.5 171.2% View Chart
Dividend Yield % 0.2 0.6 42.8%  

Financials

 LUPIN   NATCO PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-23
NATCO PHARMA
Mar-23
LUPIN/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs799847 94.4%   
Low Rs583502 116.1%   
Sales per share (Unadj.) Rs365.8148.4 246.5%  
Earnings per share (Unadj.) Rs9.839.2 25.1%  
Cash flow per share (Unadj.) Rs29.248.2 60.6%  
Dividends per share (Unadj.) Rs4.005.50 72.7%  
Avg Dividend yield %0.60.8 71.0%  
Book value per share (Unadj.) Rs270.7267.1 101.3%  
Shares outstanding (eoy) m454.98182.47 249.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.94.5 41.6%   
Avg P/E ratio x70.217.2 408.2%  
P/CF ratio (eoy) x23.714.0 169.1%  
Price / Book Value ratio x2.62.5 101.1%  
Dividend payout %40.714.0 289.7%   
Avg Mkt Cap Rs m314,381123,049 255.5%   
No. of employees `000NANA-   
Total wages/salary Rs m30,8724,867 634.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m166,41727,071 614.7%  
Other income Rs m1,5091,285 117.4%   
Total revenues Rs m167,92628,356 592.2%   
Gross profit Rs m17,2069,117 188.7%  
Depreciation Rs m8,8071,638 537.7%   
Interest Rs m2,743145 1,891.7%   
Profit before tax Rs m7,1658,619 83.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,6881,466 183.4%   
Profit after tax Rs m4,4777,153 62.6%  
Gross profit margin %10.333.7 30.7%  
Effective tax rate %37.517.0 220.6%   
Net profit margin %2.726.4 10.2%  
BALANCE SHEET DATA
Current assets Rs m124,51330,003 415.0%   
Current liabilities Rs m92,6546,831 1,356.4%   
Net working cap to sales %19.185.6 22.4%  
Current ratio x1.34.4 30.6%  
Inventory Days Days2663 41.3%  
Debtors Days Days98115 85.1%  
Net fixed assets Rs m103,49026,571 389.5%   
Share capital Rs m910365 249.3%   
"Free" reserves Rs m122,24648,373 252.7%   
Net worth Rs m123,15648,738 252.7%   
Long term debt Rs m2750-   
Total assets Rs m228,00356,574 403.0%  
Interest coverage x3.660.4 6.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.5 152.5%   
Return on assets %3.212.9 24.5%  
Return on equity %3.614.7 24.8%  
Return on capital %8.018.0 44.6%  
Exports to sales %00-   
Imports to sales %010.2 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA2,772 0.0%   
Fx inflow Rs m48,05717,256 278.5%   
Fx outflow Rs m21,7522,772 784.7%   
Net fx Rs m26,30614,484 181.6%   
CASH FLOW
From Operations Rs m18,9728,491 223.4%  
From Investments Rs m-12,868-4,771 269.7%  
From Financial Activity Rs m-3,373-3,630 92.9%  
Net Cashflow Rs m2,732208 1,313.6%  

Share Holding

Indian Promoters % 46.8 49.7 94.1%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 45.8 25.0 183.6%  
FIIs % 16.1 13.7 117.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.0 50.3 105.3%  
Shareholders   281,542 207,571 135.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Lupin vs Natco Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Lupin vs Natco Pharma Share Price Performance

Period Lupin Natco Pharma S&P BSE HEALTHCARE
1-Day 1.23% -2.11% 1.18%
1-Month 0.15% -3.19% -0.75%
1-Year 151.14% 72.80% 61.82%
3-Year CAGR 17.13% 4.96% 18.16%
5-Year CAGR 17.42% 10.96% 19.79%

* Compound Annual Growth Rate

Here are more details on the Lupin share price and the Natco Pharma share price.

Moving on to shareholding structures...

The promoters of Lupin hold a 47.0% stake in the company. In case of Natco Pharma the stake stands at 49.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Lupin and the shareholding pattern of Natco Pharma.

Finally, a word on dividends...

In the most recent financial year, Lupin paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 40.7%.

Natco Pharma paid Rs 5.5, and its dividend payout ratio stood at 14.0%.

You may visit here to review the dividend history of Lupin, and the dividend history of Natco Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.